1783Maxigen Biotech1783 info
$1.43info-0.21%24h
Global rank18535
Market cap$127.56M
Change 7d-0.74%
YTD Performance-3.99%
SP500 benchmarkUnderperform
P/E0
P/S0
Revenue$0
Earnings$0
Dividend yield-
Main Sector
Healthcare
Business data

    Maxigen Biotech (1783) Stock Overview

    Maxigen Biotech Inc. researches, develops, produces, and sells implantable medical device and cosmetic products in Taiwan, America, Europe, rest of Asia, and internationally. It operates in two segments, Biomedical Products and Consumer Products. The company offers intra-articular injections under the ArtiAid, ArtiAid Plus, and ArtiBest names to treat osteoarthritis; Foramic, a bone substitute granule; FormaGraft, a bone graft substitute; GingivAid, a collagen dental grafts for use in dental implant surgery; and BestAid, a collagen bone graft. It also provides FormaAid, a guided tissue regeneration membrane; HealiAid, a collagen wound dressing product for dental and surgical use; PreviscAid, an ophthalmic viscoelastic device; BiVisc, an ophthalmic viscoelastic system; ViscAid, an ophthalmic viscoelastic device; and dermal filler injections under the Formaderm brand. In addition, the company engages in the manufacturing and sales of beauty care products. Maxigen Biotech Inc. was incorporated in 1998 and is headquartered in Taoyuan City, Taiwan.

    1783 Stock Information

    Symbol
    1783
    Address
    No.88, Keji 1st RoadTaoyuan City, 333Taiwan
    Founded
    -
    Trading hours
    -
    Website
    https://mbi-bio.com
    Country
    🇹🇼 Taiwan
    Phone Number
    886 3 328 7222

    Maxigen Biotech (1783) Price Chart

    -
    Value:-

    Maxigen Biotech Overview: Key Details and Summary

    Stock data
    2024
    Change
    Price
    $1.43
    N/A
    Market Cap
    $127.56M
    N/A
    Shares Outstanding
    88.93M
    N/A
    Employees
    0
    N/A
    logo
    Facebook Icon
    Twitter Icon
    Linkedin Icon
    © 2024 Topstocks.org